首页> 外国专利> RECOVERED ANTIBODY (VERSIONS), A METHOD FOR PRODUCING THE ANTIBODY, AN ISOLATED NUCLEIC ACID, AN EXPRESSION CASSETTE (VERSIONS), A PLASMID (VERSIONS), A HOST CELL, A PHARMACEUTICAL PREPARATION, A KIT, A METHOD OF TREATING A PATIENT, AT RISK OF OR SUFFERING FROM ESCHERICHIA COLI INFECTION, AND A DIAGNOSTIC TECHNIQUE FOR DETERMINING ESCHERICHIA COLI INFECTIONS

RECOVERED ANTIBODY (VERSIONS), A METHOD FOR PRODUCING THE ANTIBODY, AN ISOLATED NUCLEIC ACID, AN EXPRESSION CASSETTE (VERSIONS), A PLASMID (VERSIONS), A HOST CELL, A PHARMACEUTICAL PREPARATION, A KIT, A METHOD OF TREATING A PATIENT, AT RISK OF OR SUFFERING FROM ESCHERICHIA COLI INFECTION, AND A DIAGNOSTIC TECHNIQUE FOR DETERMINING ESCHERICHIA COLI INFECTIONS

机译:恢复的抗体(版本),一种抗体的生产方法,一种分离的核酸,一种表达盒(版本),一种质粒(版本),一个宿主细胞,一种药物制剂,一种试剂盒,一种治疗患者的方法大肠埃希氏菌感染的风险或遭受的危险,以及确定大肠埃希氏菌感染的诊断技术

摘要

The invention refers to an isolated antibody that specifically binds to O25b antigen of E. coli strains comprising at least an antibody heavy chain variable region (VH), which comprises any of the CDR1 to CDR3 sequences as listed in FIG. 1, and optionally further comprising an antibody light chain variable region (VL), which comprises any of the CDR4 to CDR6 sequences as listed in FIG. 1, or functionally active CDR variants of any of the forgoing CDR 1-6 sequences.
机译:本发明涉及分离的抗体,其与大肠杆菌菌株的O25b抗原特异性结合,所述大肠杆菌菌株至少包含抗体重链可变区(VH),所述抗体重链可变区包含图1中所列的任何CDR1至CDR3序列。抗体轻链可变区(VL),其任选地还包含抗体轻链可变区(VL),其包含图1中所列的任何CDR4至CDR6序列。 1或上述任何CDR 1-6序列的功能活性CDR变体。

著录项

  • 公开/公告号RU2016135962A3

    专利类型

  • 公开/公告日2018-08-24

    原文格式PDF

  • 申请/专利权人

    申请/专利号RU20160135962

  • 发明设计人

    申请日0000-00-00

  • 分类号C07K16/12;A61K39/395;G01N33/569;C12N15/13;C12N15/63;C12N5/10;A61P31/04;

  • 国家 RU

  • 入库时间 2022-08-21 12:36:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号